APVO (STOCKS)
Aptevo Therapeutics Inc
$4.710000
+0.430000 (+10.05%)
Prev close: $4.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeffrey G. Lamothe
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.60M
- Employees
- 37
- P/E (TTM)
- —
- P/B (TTM)
- 0.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Research and Development | $14.54M |
| Operating Income/Loss | -$26.31M |
| Income/Loss From Continuing Operations After Tax | -$25.97M |
| Income/Loss From Continuing Operations Before Tax | -$25.97M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Net Income/Loss | -$25.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$25.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.57M |
| Preferred Stock Dividends And Other Adjustments | $1.57M |
| Basic Earnings Per Share | -$87.27 |
| Diluted Earnings Per Share | -$87.27 |
| Basic Average Shares | 315,535 |
| Diluted Average Shares | 315,535 |
| Assets | $27.19M |
| Current Assets | $23.08M |
| Prepaid Expenses | $609.00K |
| Other Current Assets | $22.47M |
| Noncurrent Assets | $4.11M |
| Fixed Assets | $303.00K |
| Other Non-current Assets | $3.81M |
| Liabilities | $9.81M |
| Current Liabilities | $6.05M |
| Accounts Payable | $877.00K |
| Wages | $2.42M |
| Other Current Liabilities | $2.75M |
| Noncurrent Liabilities | $3.76M |
| Equity | $17.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $17.38M |
| Liabilities And Equity | $27.19M |
| Net Cash Flow From Operating Activities | -$25.59M |
| Net Cash Flow From Operating Activities, Continuing | -$25.59M |
| Net Cash Flow From Investing Activities | -$12.91M |
| Net Cash Flow From Investing Activities, Continuing | -$12.91M |
| Net Cash Flow From Financing Activities | $38.50M |
| Net Cash Flow From Financing Activities, Continuing | $38.50M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$25.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$25.97M |
| Other Comprehensive Income/Loss | $0.00 |